Guardant Health
(NASDAQ:GH)
$18.98
0.25[1.33%]
At close: Feb 29
$18.98
0[0.00%]
After Hours: 4:30PM EDT

GET A REPORT ON GH SENT RIGHT TO YOUR INBOX

Guardant Health Stock (NASDAQ:GH), Analyst Ratings, Price Targets, Predictions

Analysts publish ratings and price targets on most stocks. Benzinga tracks 120 analyst firms so investors can understand if analysts expect a stock to trade higher or lower. Ratings are directional and typically buy, sell or hold. Price Targets are an analyst's best guess at where the stock will trade in 12 months.
Consensus Rating1
Overweight
Highest Price Target1
$160.00
Lowest Price Target1
$27.00
Consensus Price Target1
$59.59

Analyst Rating Summary1

Analyst Ratings
Sep 23
2
Oct 23
3
Nov 23
2
Dec 23
1
Jan
2
Feb
3
Strong Buy
Buy
Hold
Sell
Strong Sell

Analyst Firms Making Recommendations1

Piper Sandler
JP Morgan
Canaccord Genuity
Goldman Sachs
Guggenheim

1calculated from analyst ratings published within the last 3 years

Analyst Ratings for Guardant Health

date
ticker
Buy Now
Company
Current price
Upside/Downside
Analyst Firm
Analyst & % Accurate
Price Target Change
Rating Change
Previous / Current Rating
Get Alert
02/26/2024GHBuy Now
Guardant Health
$18.9858.06%Piper Sandler
David Westenberg
$40 → $30MaintainsOverweightGet Alert
02/23/2024GHBuy Now
Guardant Health
$18.98137.09%JP Morgan
Julia Qin
$60 → $45MaintainsOverweightGet Alert
02/23/2024GHBuy Now
Guardant Health
$18.98137.09%Canaccord Genuity
Kyle Mikson
$50 → $45MaintainsBuyGet Alert
01/30/2024GHBuy Now
Guardant Health
$18.9894.94%Goldman Sachs
Matthew Sykes
$43 → $37MaintainsBuyGet Alert
01/29/2024GHBuy Now
Guardant Health
$18.9894.94%Goldman Sachs
Matthew Sykes
$43 → $37MaintainsBuyGet Alert
12/14/2023GHBuy Now
Guardant Health
$18.98Guggenheim
Subbu Nambi
Initiates → NeutralGet Alert
12/13/2023GHBuy Now
Guardant Health
$18.98Wolfe Research
Doug Schenkel
Initiates → Peer PerformGet Alert
11/13/2023GHBuy Now
Guardant Health
$18.9842.26%Raymond James
Andrew Cooper
→ $27UpgradeMarket Perform → OutperformGet Alert
11/08/2023GHBuy Now
Guardant Health
$18.98163.44%Morgan Stanley
Shannon O'Callaghan
$55 → $50MaintainsOverweightGet Alert
10/23/2023GHBuy Now
Guardant Health
$18.98137.09%Goldman Sachs
Matthew Sykes
$52 → $45MaintainsBuyGet Alert
10/20/2023GHBuy Now
Guardant Health
$18.98137.09%Goldman Sachs
Matthew Sykes
$52 → $45MaintainsBuyGet Alert
10/02/2023GHBuy Now
Guardant Health
$18.98163.44%Citigroup
Patrick Donnelly
$50 → $50ReiteratesBuy → BuyGet Alert
09/28/2023GHBuy Now
Guardant Health
$18.9879.14%Bernstein
Eve Burstein
→ $34Initiates → OutperformGet Alert
09/27/2023GHBuy Now
Guardant Health
$18.98110.75%Piper Sandler
David Westenberg
→ $40UpgradeNeutral → OverweightGet Alert
08/08/2023GHBuy Now
Guardant Health
$18.98110.75%Piper Sandler
David Westenberg
$30 → $40MaintainsNeutralGet Alert
08/07/2023GHBuy Now
Guardant Health
$18.98189.78%Morgan Stanley
Shannon O'Callaghan
$60 → $55MaintainsOverweightGet Alert
08/04/2023GHBuy Now
Guardant Health
$18.98163.44%Citigroup
Patrick Donnelly
$40 → $50MaintainsBuyGet Alert
05/26/2023GHBuy Now
Guardant Health
$18.98110.75%Citigroup
Patrick Donnelly
→ $40UpgradeNeutral → BuyGet Alert
05/11/2023GHBuy Now
Guardant Health
$18.98216.12%Morgan Stanley
Shannon O'Callaghan
$66 → $60MaintainsOverweightGet Alert

FAQ

Q

What is the target price for Guardant Health (GH)?

A

The latest price target for Guardant Health (NASDAQ: GH) was reported by Piper Sandler on February 26, 2024. The analyst firm set a price target for $30.00 expecting GH to rise to within 12 months (a possible 58.06% upside). 23 analyst firms have reported ratings in the last year.

Q

What is the most recent analyst rating for Guardant Health (GH)?

A

The latest analyst rating for Guardant Health (NASDAQ: GH) was provided by Piper Sandler, and Guardant Health maintained their overweight rating.

Q

When is the next analyst rating going to be posted or updated for Guardant Health (GH)?

A

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Guardant Health, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Guardant Health was filed on February 26, 2024 so you should expect the next rating to be made available sometime around February 26, 2025.

Q

Is the Analyst Rating Guardant Health (GH) correct?

A

While ratings are subjective and will change, the latest Guardant Health (GH) rating was a maintained with a price target of $40.00 to $30.00. The current price Guardant Health (GH) is trading at is $18.98, which is out of the analyst’s predicted range.

Browse analyst ratings and price targets on all stocks.

People Also Watch